There are no major studies to reassess the readmission rates, a major issue in current HF practice.
It may be used in selected individuals only as add-on therapy albeit with well-known caveats like its narrow therapeutic window.
A typical example may be a patient of systolic HF in AF with faster heart rate who is not responding adequately despite routine guideline directed therapies including RAAS modulators and b blockers.
To comment on this article, create a free account.
Sign Up to instantly get access to 10000+ Articles & 1000+ Cases
eMediNexus provides latest updates on medical news, medical case studies from India. In-depth medical case studies and research designed for doctors and healthcare professionals.